FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Detlef Quietzsch

Research Profile

Chemicals & Drugs

Procedures

Disorders

Concepts & Ideas

Co-author Network

Publications

TOP 3
Ludwig Fischer von Weikersthal; Andreas Schalhorn; Martina Stauch; Detlef Quietzsch; Peter A Maubach; Helmut Lambertz; Daniel Oruzio; Rudolf Schlag; Karin Weigang-Köhler; Ute Vehling-Kaiser; Manfred Schulze; Juergen Truckenbrodt; Mariele Goebeler; Johann Mittermüller; Daniel Bosse; Borika Szukics; Marc Grundeis; Thomas Zwingers; Clemens Giessen; Volker Heinemann
Phase III trial of irinotecan plus infusional 5-fluorouracil/folinic acid versus irinotecan plus oxaliplatin as first-line treatment of advanced colorectal cancer.
Jörg Thomas Hartmann; Jan Pintoffl; Salah-Eddin Al-Batran; Detlef Quietzsch; Ines Meisinger; Marius Horger; Oliver Nehls; Carsten Bokemeyer; Alfred Königsrainer; Elke Jäger; Lothar Kanz
Mitomycin C plus infusional 5-fluorouracil in platinum-refractory gastric adenocarcinoma: an extended multicenter phase II study.
Stefan Boeck; K Weigang-Köhler; M Fuchs; Erika Kettner; Detlef Quietzsch; J Trojan; O Stötzer; S Zeuzem; Florian Lordick; Claus-Henning Köhne; H Kröning; T Steinmetz; H Depenbrock; Volker Heinemann
Second-line chemotherapy with pemetrexed after gemcitabine failure in patients with advanced pancreatic cancer: a multicenter phase II trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Detlef Quietzsch (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Ludwig Fischer von Weikersthal; Andreas Schalhorn; Martina Stauch; Detlef Quietzsch; Peter A Maubach; Helmut Lambertz; Daniel Oruzio; Rudolf Schlag; Karin Weigang-Köhler; Ute Vehling-Kaiser; Manfred Schulze; Juergen Truckenbrodt; Mariele Goebeler; Johann Mittermüller; Daniel Bosse; Borika Szukics; Marc Grundeis; Thomas Zwingers; Clemens Giessen; Volker Heinemann
Phase III trial of irinotecan plus infusional 5-fluorouracil/folinic acid versus irinotecan plus oxaliplatin as first-line treatment of advanced colorectal cancer.
European journal of cancer (Oxford, England : 1990) 2011;47(2):206-14.
2007: Jörg Thomas Hartmann; Jan Pintoffl; Salah-Eddin Al-Batran; Detlef Quietzsch; Ines Meisinger; Marius Horger; Oliver Nehls; Carsten Bokemeyer; Alfred Königsrainer; Elke Jäger; Lothar Kanz
Mitomycin C plus infusional 5-fluorouracil in platinum-refractory gastric adenocarcinoma: an extended multicenter phase II study.
Onkologie 2007;30(5):235-40.
2007: Stefan Boeck; K Weigang-Köhler; M Fuchs; Erika Kettner; Detlef Quietzsch; J Trojan; O Stötzer; S Zeuzem; Florian Lordick; Claus-Henning Köhne; H Kröning; T Steinmetz; H Depenbrock; Volker Heinemann
Second-line chemotherapy with pemetrexed after gemcitabine failure in patients with advanced pancreatic cancer: a multicenter phase II trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(4):745-51.
2007: Joerg Fahlke; Karsten Ridwelski; C Schmidt; K Hribaschek; P Stuebs; Erika Kettner; Detlef Quietzsch; Michael Assmann; T Deist; U Keilholz; Hans Lippert
A multicentre phase II study of docetaxel plus cisplatin for the treatment of advanced gastric cancer.
Chemotherapy 2007;53(6):454-60.
2006: Rudolf Fahrig; Detlef Quietzsch; Jörg-Christian Heinrich; Volker Heinemann; Stefan Boeck; Roland M Schmid; Christian Praha; Andreas Liebert; Denise Sonntag; Georg Krupitza; Mathias Hänel
RP101 improves the efficacy of chemotherapy in pancreas carcinoma cell lines and pancreatic cancer patients.
Anti-cancer drugs 2006;17(9):1045-56.
2006: Volker Heinemann; Detlef Quietzsch; Frank Gieseler; Michael Gonnermann; Herbert Schönekäs; Andreas Rost; Horst Neuhaus; Caroline Haag; Michael Clemens; Bernard Heinrich; Ursula Vehling-Kaiser; Martin Fuchs; Doris Fleckenstein; Wolfgang Gesierich; Dirk Uthgenannt; Hermann Einsele; Axel Holstege; Axel Hinke; Andreas Schalhorn; Ralf Wilkowski
Randomized phase III trial of gemcitabine plus cisplatin compared with gemcitabine alone in advanced pancreatic cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(24):3946-52.
2003: Jörg Thomas Hartmann; Karin Oechsle; Detlef Quietzsch; Axel Wein; Ralf-Dieter Hofheinz; Friedemann Honecker; O Nehls; Claus-Henning Köhne; G Käfer; Lothar Kanz; Carsten Bokemeyer
Protracted infusional 5-fluorouracil plus high-dose folinic acid combined with bolus mitomycin C in patients with gastrointestinal cancer: a phase I/II dose escalation study.
British journal of cancer 2003;89(11):2051-6.
2002: Friedemann Honecker; Christian Kollmannsberger; Detlef Quietzsch; Caroline Haag; M Schroeder; C Spott; Jörg Thomas Hartmann; W Baronius; V Hempel; Lothar Kanz; Carsten Bokemeyer
Phase II study of weekly paclitaxel plus 24-h continuous infusion 5-fluorouracil, folinic acid and 3-weekly cisplatin for the treatment of patients with advanced gastric cancer.
Anti-cancer drugs 2002;13(5):497-503.
2000: Christian Kollmannsberger; Detlef Quietzsch; Caroline Haag; T Lingenfelser; M Schroeder; Jörg Thomas Hartmann; W Baronius; V Hempel; Michael Clemens; Lothar Kanz; Carsten Bokemeyer
A phase II study of paclitaxel, weekly, 24-hour continous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancer.
British journal of cancer 2000;83(4):458-62.
1999: Jörg Thomas Hartmann; Detlef Quietzsch; Thomas Daikeler; Christian Kollmannsberger; Frank Mayer; Lothar Kanz; Carsten Bokemeyer
Mitomycin C continuous infusion as salvage chemotherapy in pretreated patients with advanced gastric cancer.
Anti-cancer drugs 1999;10(8):729-33.
1999: Andreas Liebert; Detlef Quietzsch; Lothar Beier
Comparison of the tumor associated proteases cathepsin D (CATH D) and urokinase-type plasminogen activator (uPA) in cytosols of human breast cancer patients.
Anticancer research 1999;19(4A):2571-6.
1997: Carsten Bokemeyer; Jörg Thomas Hartmann; C S Lampe; M R Clemens; Detlef Quietzsch; L Forkmann; Lothar Kanz
Paclitaxel and weekly 24-hour infusion of 5-fluorouracil/folinic acid in advanced gastric cancer.
Seminars in oncology 1997;24(6 Suppl 19):S19-96-S19-100.
1997: Carsten Bokemeyer; C S Lampe; M R Clemens; Jörg Thomas Hartmann; Detlef Quietzsch; L Forkmann; Christian Kollmannsberger; Lothar Kanz
A phase II trial of paclitaxel and weekly 24 h infusion of 5-fluorouracil/folinic acid in patients with advanced gastric cancer.
Anti-cancer drugs 1997;8(4):396-9.